OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis
Valentine Lestra, Bruno Roméo, Catherine Martelli, et al.
Schizophrenia Research (2022) Vol. 246, pp. 175-186
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 60

Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Song Chen, Yunlong Tan, Li Tian
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2834-2848
Open Access | Times Cited: 9

Immune Dysfunction in Schizophrenia Spectrum Disorders
Shiral S. Gangadin, Anne-Sophie D. Enthoven, Nico J.M. van Beveren, et al.
Annual Review of Clinical Psychology (2024) Vol. 20, Iss. 1, pp. 229-257
Closed Access | Times Cited: 8

Neuroimmune regulation of the prefrontal cortex tetrapartite synapse
A. LISS, Mahum T. Siddiqi, Paige Marsland, et al.
Neuropharmacology (2025), pp. 110335-110335
Open Access | Times Cited: 1

Epigenetic Targets in Schizophrenia Development and Therapy
Agnieszka Wawrzczak‐Bargieła, Wiktor Bilecki, Marzena Maćkowiak
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 426-426
Open Access | Times Cited: 17

Limited evidence of association between dysregulated immune marker levels and telomere length in severe mental disorders
Monica Bettina Elkjær Greenwood Ormerod, Thor Ueland, Monica Aas, et al.
Acta Neuropsychiatrica (2025) Vol. 37
Closed Access

Glial-Immune Mechanisms of Schizophrenia
Kowsar Teymouri, Mahbod Ebrahimi, Jennie G. Pouget, et al.
Oxford University Press eBooks (2025), pp. 195-208
Closed Access

Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
I. Ratke, A. Torsvik, C.A. Bartz-Johannessen, et al.
Brain Behavior & Immunity - Health (2025) Vol. 44, pp. 100959-100959
Open Access

Inflammatory markers associated with electroconvulsive therapy response in patients with depression: A meta-analysis
Annelies Dellink, Gertjan Vanderhaegen, Violette Coppens, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 170, pp. 106060-106060
Open Access

Circulating Blood-Based Proteins in Psychopathology and Cognition
Upasana Bhattacharyya, Jibin John, Max Lam, et al.
JAMA Psychiatry (2025)
Closed Access

Quality of Life and C-Reactive Protein in Patients with Schizophrenia: A Cross-Sectional Study
A. Kachouchi, Laatabi Ahmed, Karroumi Saadia, et al.
ALPHA PSYCHIATRY (2024) Vol. 25, Iss. 2, pp. 256-261
Open Access | Times Cited: 3

Retinal layers and symptoms and inflammation in schizophrenia
Marcelo Alves Carriello, Diogo F. Bornancin Costa, Pedro Henrique Pereira Alvim, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 5, pp. 1115-1124
Closed Access | Times Cited: 9

Lifestyle and mood correlates of cardiometabolic risk in people with serious mental illness on second-generation antipsychotic medications
Susanne U. Miedlich, Priya Sahay, Telva Olivares, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306798-e0306798
Open Access | Times Cited: 2

Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?
Vicent Llorca-Bofí, Miquel Bioque, M Font, et al.
Journal of Psychiatric Research (2023) Vol. 165, pp. 191-196
Open Access | Times Cited: 6

Increased markers of inflammation after cannabis cessation and their association with psychotic symptoms
Bruno Roméo, Valentine Lestra, Catherine Martelli, et al.
Acta Neuropsychiatrica (2023) Vol. 36, Iss. 2, pp. 118-127
Closed Access | Times Cited: 5

The Relationship of Cognitive Dysfunction with Inflammatory Markers and Carotid Intima Media Thickness in Schizophrenia
Okan İmre, Cüneyt Çağlayan, Mehmet Muştu
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1342-1342
Open Access | Times Cited: 5

Large-Scale Mendelian Randomization Study Reveals Circulating Blood-based Proteomic Biomarkers for Psychopathology and Cognitive Task Performance
Upasana Bhattacharyya, Jibin John, Max Lam, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Longitudinal course of inflammatory-cognitive subgroups across first treatment severe mental illness and healthy controls
Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, et al.
Psychological Medicine (2024), pp. 1-11
Closed Access | Times Cited: 1

Longitudinal course of inflammatory-cognitive subgroups across first treatment severe mental illness and healthy controls
Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Longitudinal relationships between BMI and hs-CRP among people with schizophrenia
Angelina Van Dyne, Tsung‐Chin Wu, David H. Adamowicz, et al.
Schizophrenia Research (2024) Vol. 271, pp. 337-344
Closed Access

Season of birth/C-reactive protein gene interaction differentially affects negative symptoms domains in patients with schizophrenia
Т. В. Лежейко, V. A. Mikhailova, М. В. Габаева, et al.
Neuroscience and Behavioral Physiology (2024)
Closed Access

The Inflammation in Schizophrenia: Biomarkers and Association with Pathogenesis
Evgeny A. Ermakov, Valentina N. Buneva, Svenlana A. Ivanova
Springer eBooks (2024), pp. 1-28
Closed Access

Page 1 - Next Page

Scroll to top